Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02823730 · ClinicalTrials.gov registry record
Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 500
- Enrollment target
NCT02823730 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 500 participants.
The verdict
NCT02823730 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
To compare the incidence of major adverse cardiac events among a series of patients receiving the Synergy drug-eluting stent with bioabsorbable polymer to historical controls who have received the Promus Premier drug-eluting stent with durable polymer.
Interventions
- OTHER PCI with Synergy Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-07 |
| Est. Completion | 2023-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02823730
The ClinicalTrials.gov registry entry for NCT02823730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PCI with Synergy Stent is the first listed.
NCT02823730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02823730 about?
NCT02823730 is a clinical study titled "Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy". To compare the incidence of major adverse cardiac events among a series of patients receiving the Synergy drug-eluting stent with bioabsorbable polymer to historical controls who have received the Promus Premier drug-eluting stent with durable polymer.
What is the current status of trial NCT02823730?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2016-07. Estimated completion is 2023-05.
What interventions are being tested in trial NCT02823730?
The interventions under investigation include: PCI with Synergy Stent (OTHER).
Who is sponsoring clinical trial NCT02823730?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.